Mike Yong
01-04
$Recursion Pharmaceuticals, Inc.(RXRX)$  


Will RXRX hit ATH in 2025? In the year of 2024, most AI applications like PLTR and SOUN have popped to a new ATH. 

Even though RXRX dwells in the biotech domain, it has managed to set up biohive-2, the fastest Pharma-owned supercomputer in its industry and Recursion OS with the best data-centric biology and chemistry database.

As the new generation of AI applications software emerges, RXRX along with its steadily increasing market share is expected to increase as well. And with high caliber partnerships like Google, Nvidia, Bayer, Roche, Merck, Tempus and more, RXRX differentiate Itself from other competitors.

$CRISPR Therapeutics AG(CRSP)$  which currently has a market cap of 3.5 billion is worth at least $41 USD. Don't you think that RXRX is worth 10x more?

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap
Leave a comment
1